Inovio Pharmaceuticals, Inc. (INO) Q4 2019 Earnings Call Transcript

Inovio Pharmaceuticals, Inc. (INO) Q4 2019 Earnings Call Transcript

[Operator Instructions] After today's presentation, there will be an opportunity to ask questions.. I would now like to turn the conference call over to Ben Matone, Senior Director of Investor Relations.. Good afternoon and thank you for joining the Inovio Pharmaceuticals' fourth quarter and year end 2019 investor conference call.. With me today are Inovio's President and CEO, Dr. J. Joseph Kim; our Chief Financial Officer, Mr. Peter Kies; and Senior VP of Research and Development Dr. Kate Broderick, who will provide an overview on Inovio's continued efforts regarding the company's DNA vaccine which is targeting the current COVID-19 outbreak.. Today's call is being webcast live on our website, ir.inovio.com and a replay of today's call will be made available.. I would now like to turn the call over to Inovio's President and CEO, Dr. J. Joseph Kim.. And while investor attention over the last couple months has been on our COVID-19 vaccine development, this call is timely, as I think it allows us to reconnect investors to our core fundamental and pipeline programs and exciting upcoming data catalysts.. But before the update on our core pipeline programs and our upcoming catalysts, I would like to address the emerging novel